Lynn, MA, United States of America

Lisa Duong

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Calixa Therapeutics, Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lisa Duong. Retrieved from https://idiyas.com/inventor/lisa-duong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Lisa Duong and Her Contribution to Pharmaceutical Science

Introduction: Lisa Duong is a notable inventor based in Lynn, MA, whose work has contributed significantly to the field of pharmaceuticals. With a keen focus on innovative drug formulations, she holds a patent that highlights her dedication to advancing medical science.

Latest Patents: Lisa Duong is the inventor of a pivotal patent titled "Solid forms of ceftolozane." This patent describes novel solid forms of ceftolozane and outlines methods for their preparation and use. This innovation holds promise in improving the efficacy and stability of this important therapeutic compound.

Career Highlights: Lisa currently works at Calixa Therapeutics, Inc., where she develops groundbreaking pharmaceutical solutions. Her innovative approach has positioned her as a valuable asset in the therapeutic development landscape.

Collaborations: In her role, Lisa collaborates with talented professionals, including You Seok Hwang and Nicole Miller Damour. Together, they contribute to a dynamic team focused on advancing healthcare solutions.

Conclusion: Lisa Duong's work exemplifies the spirit of innovation within the pharmaceutical industry. Her patented invention of solid forms of ceftolozane reflects her commitment to enhancing drug delivery systems and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…